Navigation Links
CVS Caremark Launches Chronic Cardiovascular Disease Medication Adherence Program

WOONSOCKET, R.I., Nov. 9, 2011 /PRNewswire/ -- In an effort to attack the high costs of cardiovascular  illnesses and to improve the treatment outcomes of cardiac patients, CVS Caremark (NYSE: CVS) has launched Pharmacy Advisor™ for chronic cardiovascular care, a pharmacy-based approach to managing one of the most prevalent and expensive chronic illnesses.


The program, which combines pharmacy benefit management (PBM) insights and solutions with pharmacist interventions, ensures that patients follow their medication regimens to achieve optimal health outcomes.  Pharmacy Advisor™ for chronic cardiovascular care will initially focus on improving medication adherence for four conditions: high blood pressure, high cholesterol, coronary artery disease (CAD) and congestive heart failure (CHF).  High blood pressure alone affects one in three adults and costs the health care system approximately $76 billion a year.

"As a pharmacy innovation company, it is our responsibility to continue to find new and effective ways to help people on their path to better health," said Helena Foulkes, executive vice president, Chief Health Care Strategy and Marketing Officer for CVS Caremark. "The introduction of the Pharmacy Advisor program for chronic cardiovascular conditions allows us to take a new approach to an old challenge.  This is another example of how we combine our research and pharmacy care expertise with our unparalleled access to consumers to make a difference for PBM clients and their members."

The launch of Pharmacy Advisor™ for chronic cardiovascular conditions follows recent research conducted by CVS Caremark, Harvard University and Brigham and Women's Hospital that quantified for the first time how much can be saved per patient by improving medication adherence for common chronic  diseases. The research, published this past January in the journal Health Affairs, found that patients with hypertension who took their medications as prescribed saved nearly $4,000 per year, patients with high cholesterol saved up to $1,200 per year and CHF patients saved nearly $8,000 annually.

Through Pharmacy Advisor™, CVS Caremark engages PBM members who are diagnosed with chronic conditions, including diabetes and cardiovascular disease, according to their expressed preferences at points when they are most receptive to messages about their prescribed therapy:  face-to-face when members choose to fill prescriptions at CVS/pharmacy or by phone when members choose home delivery. The use of these integrated tactics drives behavior change in the short term and over time and leads to better clinical outcomes. In addition to improving medication adherence, thus saving money and improving the quality of treatment, the program closes gaps in care and directs members with chronic conditions to existing disease management programs where they can obtain additional support.

The approach to Pharmacy Advisor is informed by CVS Caremark-sponsored research that has shown that counseling with a trusted health care professional is highly effective when it comes to improving medication adherence for patients with heart disease.  In fact, pharmacists at retail drug stores were found to be the most influential voice in encouraging patients to take their medication as prescribed.

"The Pharmacy Advisor program improves clinical care because we are able to identify and address pharmacy-related care issues that if left unattended could result in disease progression and increased health care costs," said Troyen A. Brennan, MD, MPH, executive vice president and Chief Medical Officer of CVS Caremark.  "We are also better able to engage the member in their care through multiple contact points, providing counsel that can improve adherence and help members optimize their pharmacy benefit and find the most cost effective options."

Last January, CVS Caremark launched Pharmacy Advisor for diabetes, which has successfully facilitated more than 1.7 million member interventions.  More than 700 clients representing approximately 12.5 million members will be enrolled in the diabetes program by the end of the year.

About CVS Caremark

CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at

Media Contacts:
Christine K. Cramer
CVS Caremark

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Hosts Live Facebook Chats for American Diabetes Month
2. CVS Caremark Reports Third Quarter Results
3. CVS Caremark to Present at Upcoming Conferences
4. CVS Caremark Sponsored Research Finds Twenty Four Percent of New Prescriptions Never Filled
5. CVS Caremark Partners With Hispanic Heritage Foundation to Identify and Inspire Future Latino Health Care Leaders
6. CVS Caremark Donating $6 Million in Free Flu Shots to Direct Relief USA for Uninsured Patients of Community Clinics and Health Centers
7. CVS Caremark Charitable Trust and CVS/pharmacy Provide Over $100,000 in Disaster Relief To Communities Impacted by Hurricane Irene
8. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock
9. CVS Caremark Corporation Announces Receipt of Requisite Consents, Termination of Replacement Capital Covenant and Expiration of Consent Solicitation Relating to its 6.125% Senior Notes due August 15, 2016 (CUSIP NO. 126650BE9)
10. CVS Caremark Appoints Mark S. Cosby as President of CVS/pharmacy
11. CVS Caremark, Harvard and Brigham and Womens Researchers Say Medicare Donut Hole Can Lead to a Decrease in Medication Adherence
Post Your Comments:
(Date:10/13/2015)... 13, 2015  Vitamin Angels – a charity that ... need of nutritional support - announced its work continues ... Nations (UN). The UN,s newly established Global Goals - ... recent follow up to the Millennium Development Goals established ... The new 17 Global Goals intend to address three ...
(Date:10/13/2015)... Generational Equity , a leading mergers and acquisitions advisor ... acquisition of its client, Quality Medical Rentals ... by Meridian Biomedical, Inc. (Meridian), headquartered in Colorado.  The ... Florida . To learn more, visit ... To learn more, visit . --> ...
(Date:10/13/2015)... -- The spine division of Zimmer Biomet (NYSE and SIX: ... its portfolio of innovative clinical solutions and technologies at ... 14-17, 2015, in Chicago , Illinois.  ... "Supplemental MIS Fixation Options for LLIF" NASS ... 1 p.m. --> "Supplemental MIS Fixation Options ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... Vision Group Holdings, the largest LASIK provider in ... brands including The LASIK Vision Institute and TLC Laser Eye Centers, Vision Group Holdings ... laser vision correction. , Global Laser Vision will continue to operate in San Diego ...
(Date:10/13/2015)... ... October 13, 2015 , ... PhyMed Healthcare Group ... announced its partnership with WPC Healthcare , a provider of predictive analytics ... the data into an aggregated data repository necessary to perform reporting and analytics ...
(Date:10/13/2015)... ... October 13, 2015 , ... Symposium Chairman, Dr. Rod J. ... Dallas Cosmetic Symposium to be held March 2nd and 3rd, 2016. The annual meeting, ... plastic surgeons and cosmetic physicians from around the world. , Key topics at this ...
(Date:10/13/2015)... ... October 13, 2015 , ... e-con Systems Inc., a leading embedded design ... the industry’s first RGB-IR pixel format camera with a USB 3.0 interface and ... See3CAM family of UVC USB 3.0 cameras, is based on the 1/3-inch OV4682 - ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... today their Title Sponsorship of Synergy 2015. The annual WennSoft KEY2ACT user conference ... Valley Ranch and will unite customers, partners, WennSoft team members and sponsors to ...
Breaking Medicine News(10 mins):